Trials / Completed
CompletedNCT02479945
Peripheral vs. Selective Tumor Marker Venous Sampling in Prostate Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- Male
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The investigators will compare tumor marker levels, including PSA, in samples taken from a peripheral upper limb vein and the internal iliac veins. These will be collected from patients who are scheduled for prostatectomy as part of their standard of care for prostate cancer. A selective internal iliac vein sampling procedure will be performed in Interventional Radiology. Venous samples will be correlated with prostatectomy specimens. The aim is to predict the side of the prostate containing tumor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Obtaining biospecimen |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2012-12-01
- Completion
- 2013-04-25
- First posted
- 2015-06-24
- Last updated
- 2020-07-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02479945. Inclusion in this directory is not an endorsement.